INOVIO to present at two major healthcare investor conferences in September 2026

INOVIO, a biotechnology company specializing in DNA medicines for HPV-related diseases, cancer, and infectious diseases, announced its participation in two upcoming investor conferences in New York: the Cantor Global Healthcare Conference on September 9 and the H.C. Wainwright 28th Annual Global Investment Conference starting September 11. The company will host a fireside chat and virtual presentations, with replays available for 90 days. These events provide INOVIO an opportunity to engage with investors and showcase its innovative DNA medicine technology.